Your payment is in progress...
  +1 (704) 266-3234

Global Neurodegenerative Diseases Market Insights, Forecast To 2025

Published on: Jun 2019 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 123

Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), leading to progressive decline in functional neurological capacities. It has a devastating effect on quality of life and independence, often requiring full-time care during the later disease stages.
The global Neurodegenerative Diseases market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Neurodegenerative Diseases market based on company, product type, end user and key regions.

This report studies the global market size of Neurodegenerative Diseases in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neurodegenerative Diseases in these regions.
This research report categorizes the global Neurodegenerative Diseases market by top players/brands, region, type and end user. This report also studies the global Neurodegenerative Diseases market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Merck Serono
Teva Pharmaceutical
UCB
Pfizer
Biogen Idec
Bayer Schering Pharma AG
Boehringer Ingelheim
Addex Pharmaceutical
Amarin
AstraZeneca
Asubio Pharmaceutical
Bial
Alector
Yumanity Therapeutics
Eisai
H.Lundbeck A/S
Jiangsu Hansoh Pharmaceutical
Yangtze River Pharmaceutical Group
Chongqing Zein Pharmaceutical

Market size by Product
NMDA
SSRIs
Dopamine Inhibitors
Market size by End User
Parkinson’s disease
Huntington disease
Amyotrophic Lateral Sclerosis
Alzheimer’s disease

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Neurodegenerative Diseases market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Neurodegenerative Diseases market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neurodegenerative Diseases companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neurodegenerative Diseases submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Neurodegenerative Diseases are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neurodegenerative Diseases market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Neurodegenerative Diseases Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Neurodegenerative Diseases Market Size Growth Rate by Product
1.4.2 NMDA
1.4.3 SSRIs
1.4.4 Dopamine Inhibitors
1.5 Market by End User
1.5.1 Global Neurodegenerative Diseases Market Size Growth Rate by End User
1.5.2 Parkinson√ēs disease
1.5.3 Huntington disease
1.5.4 Amyotrophic Lateral Sclerosis
1.5.5 Alzheimer√ēs disease
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Neurodegenerative Diseases Market Size
2.1.1 Global Neurodegenerative Diseases Revenue 2014-2025
2.1.2 Global Neurodegenerative Diseases Sales 2014-2025
2.2 Neurodegenerative Diseases Growth Rate by Regions
2.2.1 Global Neurodegenerative Diseases Sales by Regions
2.2.2 Global Neurodegenerative Diseases Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Neurodegenerative Diseases Sales by Manufacturers
3.1.1 Neurodegenerative Diseases Sales by Manufacturers
3.1.2 Neurodegenerative Diseases Sales Market Share by Manufacturers
3.1.3 Global Neurodegenerative Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Neurodegenerative Diseases Revenue by Manufacturers
3.2.1 Neurodegenerative Diseases Revenue by Manufacturers (2014-2019)
3.2.2 Neurodegenerative Diseases Revenue Share by Manufacturers (2014-2019)
3.3 Neurodegenerative Diseases Price by Manufacturers
3.4 Neurodegenerative Diseases Manufacturing Base Distribution, Product Types
3.4.1 Neurodegenerative Diseases Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neurodegenerative Diseases Product Type
3.4.3 Date of International Manufacturers Enter into Neurodegenerative Diseases Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Neurodegenerative Diseases Sales by Product
4.2 Global Neurodegenerative Diseases Revenue by Product
4.3 Neurodegenerative Diseases Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Neurodegenerative Diseases Breakdown Data by End User

6 North America
6.1 North America Neurodegenerative Diseases by Countries
6.1.1 North America Neurodegenerative Diseases Sales by Countries
6.1.2 North America Neurodegenerative Diseases Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Neurodegenerative Diseases by Product
6.3 North America Neurodegenerative Diseases by End User

7 Europe
7.1 Europe Neurodegenerative Diseases by Countries
7.1.1 Europe Neurodegenerative Diseases Sales by Countries
7.1.2 Europe Neurodegenerative Diseases Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neurodegenerative Diseases by Product
7.3 Europe Neurodegenerative Diseases by End User

8 Asia Pacific
8.1 Asia Pacific Neurodegenerative Diseases by Countries
8.1.1 Asia Pacific Neurodegenerative Diseases Sales by Countries
8.1.2 Asia Pacific Neurodegenerative Diseases Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Neurodegenerative Diseases by Product
8.3 Asia Pacific Neurodegenerative Diseases by End User

9 Central & South America
9.1 Central & South America Neurodegenerative Diseases by Countries
9.1.1 Central & South America Neurodegenerative Diseases Sales by Countries
9.1.2 Central & South America Neurodegenerative Diseases Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Neurodegenerative Diseases by Product
9.3 Central & South America Neurodegenerative Diseases by End User

10 Middle East and Africa
10.1 Middle East and Africa Neurodegenerative Diseases by Countries
10.1.1 Middle East and Africa Neurodegenerative Diseases Sales by Countries
10.1.2 Middle East and Africa Neurodegenerative Diseases Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Neurodegenerative Diseases by Product
10.3 Middle East and Africa Neurodegenerative Diseases by End User

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Neurodegenerative Diseases Products Offered
11.1.5 Novartis Recent Development
11.2 Merck Serono
11.2.1 Merck Serono Company Details
11.2.2 Company Business Overview
11.2.3 Merck Serono Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Serono Neurodegenerative Diseases Products Offered
11.2.5 Merck Serono Recent Development
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Details
11.3.2 Company Business Overview
11.3.3 Teva Pharmaceutical Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva Pharmaceutical Neurodegenerative Diseases Products Offered
11.3.5 Teva Pharmaceutical Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 Company Business Overview
11.4.3 UCB Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.4.4 UCB Neurodegenerative Diseases Products Offered
11.4.5 UCB Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Neurodegenerative Diseases Products Offered
11.5.5 Pfizer Recent Development
11.6 Biogen Idec
11.6.1 Biogen Idec Company Details
11.6.2 Company Business Overview
11.6.3 Biogen Idec Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Biogen Idec Neurodegenerative Diseases Products Offered
11.6.5 Biogen Idec Recent Development
11.7 Bayer Schering Pharma AG
11.7.1 Bayer Schering Pharma AG Company Details
11.7.2 Company Business Overview
11.7.3 Bayer Schering Pharma AG Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Bayer Schering Pharma AG Neurodegenerative Diseases Products Offered
11.7.5 Bayer Schering Pharma AG Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Company Business Overview
11.8.3 Boehringer Ingelheim Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Boehringer Ingelheim Neurodegenerative Diseases Products Offered
11.8.5 Boehringer Ingelheim Recent Development
11.9 Addex Pharmaceutical
11.9.1 Addex Pharmaceutical Company Details
11.9.2 Company Business Overview
11.9.3 Addex Pharmaceutical Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Addex Pharmaceutical Neurodegenerative Diseases Products Offered
11.9.5 Addex Pharmaceutical Recent Development
11.10 Amarin
11.10.1 Amarin Company Details
11.10.2 Company Business Overview
11.10.3 Amarin Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Amarin Neurodegenerative Diseases Products Offered
11.10.5 Amarin Recent Development
11.11 AstraZeneca
11.12 Asubio Pharmaceutical
11.13 Bial
11.14 Alector
11.15 Yumanity Therapeutics
11.16 Eisai
11.17 H.Lundbeck A/S
11.18 Jiangsu Hansoh Pharmaceutical
11.19 Yangtze River Pharmaceutical Group
11.20 Chongqing Zein Pharmaceutical

12 Future Forecast
12.1 Neurodegenerative Diseases Market Forecast by Regions
12.1.1 Global Neurodegenerative Diseases Sales Forecast by Regions 2019-2025
12.1.2 Global Neurodegenerative Diseases Revenue Forecast by Regions 2019-2025
12.2 Neurodegenerative Diseases Market Forecast by Product
12.2.1 Global Neurodegenerative Diseases Sales Forecast by Product 2019-2025
12.2.2 Global Neurodegenerative Diseases Revenue Forecast by Product 2019-2025
12.3 Neurodegenerative Diseases Market Forecast by End User
12.4 North America Neurodegenerative Diseases Forecast
12.5 Europe Neurodegenerative Diseases Forecast
12.6 Asia Pacific Neurodegenerative Diseases Forecast
12.7 Central & South America Neurodegenerative Diseases Forecast
12.8 Middle East and Africa Neurodegenerative Diseases Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neurodegenerative Diseases Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Neurodegenerative Diseases Product Picture
Table Neurodegenerative Diseases Market Segments
Table Key Manufacturers Neurodegenerative Diseases Covered
Table Global Neurodegenerative Diseases Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Neurodegenerative Diseases Sales Market Share by Product 2014-2025
Figure NMDA Product Picture
Table Major Manufacturers of NMDA
Figure SSRIs Product Picture
Table Major Manufacturers of SSRIs
Figure Dopamine Inhibitors Product Picture
Table Major Manufacturers of Dopamine Inhibitors
Table Global Neurodegenerative Diseases Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Parkinson’s disease
Figure Huntington disease
Figure Amyotrophic Lateral Sclerosis
Figure Alzheimer’s disease
Figure Neurodegenerative Diseases Report Years Considered
Figure Global Neurodegenerative Diseases Market Size 2014-2025 (Million US$)
Figure Global Neurodegenerative Diseases Sales 2014-2025 (K Units)
Table Global Neurodegenerative Diseases Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Neurodegenerative Diseases Sales by Regions 2014-2019 (K Units)
Table Global Neurodegenerative Diseases Sales Market Share by Regions 2014-2019
Figure Global Neurodegenerative Diseases Sales Market Share by Regions 2014-2019
Figure 2018 Global Neurodegenerative Diseases Sales Market Share by Regions
Table Global Neurodegenerative Diseases Revenue by Regions 2014-2019 (Million US$)
Table Global Neurodegenerative Diseases Revenue Market Share by Regions 2014-2019
Figure Global Neurodegenerative Diseases Revenue Market Share by Regions 2014-2019
Figure 2018 Global Neurodegenerative Diseases Revenue Market Share by Regions
Table Global Neurodegenerative Diseases Sales by Manufacturers (2014-2019) (K Units)
Table Global Neurodegenerative Diseases Sales Share by Manufacturers (2014-2019)
Figure Global Neurodegenerative Diseases Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Neurodegenerative Diseases Revenue by Manufacturers (2014-2019) (Million USD)
Table Neurodegenerative Diseases Revenue Share by Manufacturers (2014-2019)
Figure Neurodegenerative Diseases Value Share by Manufacturers in 2018
Table Key Manufacturers Neurodegenerative Diseases Price (2014-2019) (USD/Unit)
Table Neurodegenerative Diseases Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Neurodegenerative Diseases Product Type
Table Date of International Manufacturers Enter into Neurodegenerative Diseases Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Global Neurodegenerative Diseases Sales Share by Product (2014-2019)
Figure Global Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure Global Neurodegenerative Diseases Sales Market Share by Product in 2018
Table Global Neurodegenerative Diseases Revenue by Product (2014-2019) (Million US$)
Table Global Neurodegenerative Diseases Revenue Share by Product (2014-2019)
Figure Global Neurodegenerative Diseases Revenue Market Share by Product (2014-2019)
Figure Global Neurodegenerative Diseases Revenue Market Share by Product in 2018
Table Neurodegenerative Diseases Price by Product 2014-2019 (USD/Unit)
Table Global Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Global Neurodegenerative Diseases Sales Share by End User (2014-2019)
Figure Global Sales Neurodegenerative Diseases Market Share by End User (2014-2019)
Figure Global Sales Neurodegenerative Diseases Market Share by End User in 2018
Figure North America Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure North America Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table North America Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table North America Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 North America Neurodegenerative Diseases Sales Market Share by Countries
Table North America Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table North America Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Neurodegenerative Diseases Revenue Market Share by Countries
Figure United States Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure United States Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Canada Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table North America Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table North America Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 North America Neurodegenerative Diseases Market Share by Product
Table North America Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table North America Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 North America Neurodegenerative Diseases Market Share by End User
Figure Europe Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure Europe Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table Europe Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Neurodegenerative Diseases Sales Market Share by Countries
Table Europe Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table Europe Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Neurodegenerative Diseases Revenue Market Share by Countries
Figure Germany Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Germany Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure France Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure France Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure UK Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Italy Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Russia Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Europe Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 Europe Neurodegenerative Diseases Market Share by Product
Table Europe Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Europe Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 Europe Neurodegenerative Diseases Market Share by End User
Figure Asia Pacific Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Neurodegenerative Diseases Sales Market Share by Countries
Table Asia Pacific Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Neurodegenerative Diseases Revenue Market Share by Countries
Figure China Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure China Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Japan Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Korea Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure India Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure India Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Australia Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Neurodegenerative Diseases Market Share by Product
Table Asia Pacific Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Asia Pacific Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Neurodegenerative Diseases Market Share by End User
Figure Central & South America Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table Central & South America Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Neurodegenerative Diseases Sales Market Share by Countries
Table Central & South America Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Neurodegenerative Diseases Revenue Market Share by Countries
Figure Brazil Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Central & South America Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Neurodegenerative Diseases Market Share by Product
Table Central & South America Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Central & South America Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Neurodegenerative Diseases Market Share by End User
Figure Middle East and Africa Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries
Table Middle East and Africa Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries
Figure GCC Countries Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Neurodegenerative Diseases Market Share by Product
Table Middle East and Africa Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Neurodegenerative Diseases Market Share by End User
Table Novartis Company Details
Table Novartis Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development

Table Merck Serono Company Details
Table Merck Serono Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Serono Recent Development

Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Recent Development

Table UCB Company Details
Table UCB Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table UCB Recent Development

Table Pfizer Company Details
Table Pfizer Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Biogen Idec Company Details
Table Biogen Idec Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Idec Recent Development

Table Bayer Schering Pharma AG Company Details
Table Bayer Schering Pharma AG Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Schering Pharma AG Recent Development

Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development

Table Addex Pharmaceutical Company Details
Table Addex Pharmaceutical Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Addex Pharmaceutical Recent Development

Table Amarin Company Details
Table Amarin Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amarin Recent Development

Table AstraZeneca Company Details
Table Asubio Pharmaceutical Company Details
Table Bial Company Details
Table Alector Company Details
Table Yumanity Therapeutics Company Details
Table Eisai Company Details
Table H.Lundbeck A/S Company Details
Table Jiangsu Hansoh Pharmaceutical Company Details
Table Yangtze River Pharmaceutical Group Company Details
Table Chongqing Zein Pharmaceutical Company Details
Table Global Neurodegenerative Diseases Sales Forecast by Regions 2019-2025 (K Units)
Table Global Neurodegenerative Diseases Sales Market Share Forecast by Regions 2019-2025
Table Global Neurodegenerative Diseases Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Regions 2019-2025
Table Global Neurodegenerative Diseases Sales Forecast by Product 2019-2025 (K Units)
Table Global Neurodegenerative Diseases Sales Market Share Forecast by Product 2019-2025
Table Global Neurodegenerative Diseases Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Product 2019-2025
Table Global Neurodegenerative Diseases Sales Forecast by End User 2019-2025 (K Units)
Table Global Neurodegenerative Diseases Sales Market Share Forecast by End User 2019-2025
Figure North America Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Neurodegenerative Diseases Value Chain
Table Neurodegenerative Diseases Customers List
Table Neurodegenerative Diseases Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.